{"hands_on_practices": [{"introduction": "A cornerstone of neuropsychological assessment is determining if a patient's performance is significantly different from that of their healthy peers. This exercise introduces the standard score, or $z$-score, a fundamental statistical tool that standardizes a raw test score, allowing for a clear, objective measure of cognitive impairment. Mastering this calculation and its interpretation is the first step in translating raw data into clinically meaningful evidence for a diagnosis like Vascular Neurocognitive Disorder [@problem_id:4771243].", "problem": "A $72$-year-old adult with long-standing hypertension and confluent periventricular white matter hyperintensities on magnetic resonance imaging is undergoing evaluation for suspected vascular neurocognitive disorder. On a standardized processing speed task whose scores in age-, sex-, and education-matched community controls are approximately normally distributed with population mean $50$ and population standard deviation (SD) $10$, the patient’s observed score is $35$. Under the normal model for standardized psychometric scaling, derive from first principles the transformation that converts an observed score to a standardized deviation relative to the population mean, and compute the resulting unit-normalized value for this patient. Provide the exact value of the standardized score; no rounding is required. Express your final answer as a unitless number. In your reasoning, address whether the magnitude of deviation would be considered clinically significant in the context of vascular neurocognitive disorder assessment, based on widely used neuropsychological conventions for impairment thresholds.", "solution": "The problem as stated is scientifically grounded, well-posed, objective, and contains all necessary information for a complete solution. It is therefore deemed valid.\n\nThe problem asks for two main components: first, to derive from first principles the transformation that converts an observed score into a standardized deviation, and second, to compute this value for the specified patient and comment on its clinical significance.\n\nLet $X$ be a random variable representing an observed score from a population distribution with a finite mean $\\mu = E[X]$ and a finite, non-zero standard deviation $\\sigma = \\sqrt{\\text{Var}(X)}$. The population of scores for the standardized processing speed task is given to be approximately normal, with a mean $\\mu = 50$ and a standard deviation $\\sigma = 10$. The patient's observed score is a specific realization of this process, denoted by $x = 35$.\n\nOur objective is to derive a transformation that converts the observed score $x$ into a unit-normalized value, commonly known as a standard score or z-score. A standard score, let's call it $Z$, is a random variable that, by definition, has a mean of $0$ and a standard deviation of $1$.\n\nThe derivation proceeds in two steps: centering and scaling.\n\nFirst, we center the variable $X$ by subtracting its mean, $\\mu$. Let us define a new variable, $X'$, as:\n$$X' = X - \\mu$$\nThe expected value (mean) of this new variable $X'$ is:\n$$E[X'] = E[X - \\mu] = E[X] - E[\\mu]$$\nSince $\\mu$ is a constant, its expected value is itself, $E[\\mu] = \\mu$. Therefore:\n$$E[X'] = \\mu - \\mu = 0$$\nThis transformation has shifted the distribution's mean to $0$. Now, we examine the variance of $X'$. The variance is unaffected by the addition or subtraction of a constant, so:\n$$\\text{Var}(X') = \\text{Var}(X - \\mu) = \\text{Var}(X) = \\sigma^2$$\nThe standard deviation of $X'$ is thus $\\text{SD}(X') = \\sqrt{\\text{Var}(X')} = \\sigma$.\n\nSecond, we scale the centered variable $X'$ by its standard deviation, $\\sigma$. We define the standardized variable $Z$ as:\n$$Z = \\frac{X'}{\\sigma} = \\frac{X - \\mu}{\\sigma}$$\nThis is the general transformation from an observed score to a standardized score. To verify that this transformation meets the requirements, we compute the mean and standard deviation of $Z$.\n\nThe mean of $Z$ is:\n$$E[Z] = E\\left[\\frac{X - \\mu}{\\sigma}\\right] = \\frac{1}{\\sigma} E[X - \\mu] = \\frac{1}{\\sigma}(0) = 0$$\nThe variance of $Z$ is:\n$$\\text{Var}(Z) = \\text{Var}\\left(\\frac{X - \\mu}{\\sigma}\\right)$$\nUsing the property that $\\text{Var}(aY) = a^2 \\text{Var}(Y)$ for a constant $a$ and random variable $Y$, we have:\n$$\\text{Var}(Z) = \\left(\\frac{1}{\\sigma}\\right)^2 \\text{Var}(X - \\mu) = \\frac{1}{\\sigma^2} \\text{Var}(X)$$\nSince $\\text{Var}(X) = \\sigma^2$, we get:\n$$\\text{Var}(Z) = \\frac{1}{\\sigma^2} (\\sigma^2) = 1$$\nThe standard deviation of $Z$ is the square root of its variance:\n$$\\text{SD}(Z) = \\sqrt{\\text{Var}(Z)} = \\sqrt{1} = 1$$\nThus, the transformation $Z = \\frac{X - \\mu}{\\sigma}$ correctly converts a score $X$ from a distribution with mean $\\mu$ and standard deviation $\\sigma$ to a standardized score $Z$ with mean $0$ and standard deviation $1$. This derivation from first principles is complete.\n\nNow, we apply this transformation to the patient's data. The given values are:\nPatient's observed score, $x = 35$.\nPopulation mean, $\\mu = 50$.\nPopulation standard deviation, $\\sigma = 10$.\n\nThe patient's standardized score, $z$, is calculated as:\n$$z = \\frac{x - \\mu}{\\sigma} = \\frac{35 - 50}{10} = \\frac{-15}{10} = -1.5$$\nThe resulting unit-normalized value for this patient is exactly $-1.5$. This means the patient's performance on the processing speed task is $1.5$ standard deviations below the average performance of their age-, sex-, and education-matched peers.\n\nRegarding the clinical significance of this finding in the context of vascular neurocognitive disorder assessment: in clinical neuropsychology, a z-score is a direct measure of how an individual's performance deviates from the normative group. While conventions can vary slightly, a widely used threshold for defining cognitive impairment is a performance level of $1.5$ standard deviations or more below the normative mean (i.e., a z-score of $-1.5$ or lower). Performance between $-1.0$ and $-1.5$ standard deviations is often considered \"borderline\" or \"mildly impaired,\" while performance below $-1.5$ standard deviations is typically classified as a clear deficit (e.g., \"moderately impaired\").\n\nTherefore, a standardized score of $-1.5$ is considered clinically significant. It indicates a deficit in processing speed that falls at the threshold for, or within the range of, moderate impairment. This finding, in conjunction with the patient's history of hypertension and MRI evidence of confluent white matter hyperintensities (which are indicative of small vessel cerebrovascular disease), is highly consistent with the diagnostic criteria for vascular neurocognitive disorder. Deficits in executive functions and processing speed are hallmark features of this condition. A deviation of this magnitude on a relevant cognitive test provides strong, quantitative evidence supporting the clinical suspicion.", "answer": "$$\\boxed{-1.5}$$", "id": "4771243"}, {"introduction": "A diagnosis of neurocognitive disorder hinges not just on objective test performance, but on whether cognitive deficits impact a person's ability to function independently in daily life. This practice explores the critical role of informant-based functional scales in distinguishing between mild and major neurocognitive disorder, a key diagnostic decision. It highlights how real-world functional impairment, especially in complex tasks affected by vascular-type deficits, is crucial evidence [@problem_id:4771233].", "problem": "A $68$-year-old man with long-standing hypertension and type $2$ diabetes mellitus experienced a minor lacunar stroke $3$ months ago. He reports “feeling slower” but insists he remains independent. His Montreal Cognitive Assessment (MoCA) score is $24/30$. On a brief neuropsychological battery, processing speed and executive functioning are modestly impaired relative to age-, sex-, and education-adjusted norms (for example, Trail Making Test Part B and Digit Symbol Coding both approximately $-1.5$ to $-1.8$ standard deviations), whereas verbal learning and delayed recall are within $-0.5$ standard deviations of the mean. He completes basic Activities of Daily Living (ADL) without assistance, but his daughter reports new difficulties since the stroke: missed bill payments, errors in medication management requiring her to set up a weekly pillbox, and trouble planning multi-step tasks. Magnetic resonance imaging shows periventricular white matter hyperintensities and several small lacunes consistent with chronic small vessel ischemic disease.\n\nThe evaluating clinician seeks to determine whether the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) criteria are met for mild versus major vascular neurocognitive disorder. She considers adding an informant-based functional measure such as the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE), the Functional Activities Questionnaire (FAQ), or the Amsterdam Instrumental Activities of Daily Living (IADL) Questionnaire, in addition to cognitive testing.\n\nFrom first principles of DSM-5-TR nosology, psychometric assessment, and the clinical phenotype of vascular neurocognitive disorder, which of the following are the most defensible arguments for adding an informant-based functional scale alongside cognitive testing in this case? Select all that apply.\n\nA. Informant-based functional scales provide direct evidence about interference with independence in everyday activities, which is necessary to distinguish mild from major neurocognitive disorder under DSM-5-TR, and are particularly sensitive to instrumental activities affected by executive and processing speed deficits typical of vascular disease.\n\nB. DSM-5-TR requires informant report to make any neurocognitive disorder diagnosis; therefore, adding an informant-based functional scale is mandatory regardless of cognitive testing results.\n\nC. If the informant endorses a stepwise decline after cerebrovascular events, this obviates the need for neuroimaging or neurological examination to establish the vascular etiology required by DSM-5-TR.\n\nD. Informant-based functional scales allow the clinician to directly re-norm cognitive test scores for education and culture, thereby replacing the need for psychometric norms when applying DSM-5-TR severity thresholds.\n\nE. Informant-based functional scales can satisfy the DSM-5-TR requirement for evidence of decline based on concern from a knowledgeable informant, complementing objective cognitive performance to reach diagnostic thresholds.", "solution": "The question requires reasoning from the core DSM-5-TR definitions of mild versus major neurocognitive disorder, principles of psychometrics, and typical clinical features of vascular neurocognitive disorder.\n\nStart from DSM-5-TR core definitions. DSM-5-TR defines neurocognitive disorders by requiring: (i) evidence of cognitive decline from a previous level of performance in one or more cognitive domains, based on concern from the individual, a knowledgeable informant, or the clinician, and (ii) impairment in cognitive performance on objective testing. The severity distinction is anchored to daily function: for mild neurocognitive disorder, the cognitive deficits do not interfere with independence in everyday activities (greater effort, compensatory strategies, or accommodations may be required), whereas for major neurocognitive disorder, the cognitive deficits interfere with independence in everyday activities, typically requiring assistance with complex instrumental activities of daily living (IADL) such as paying bills, managing medications, or organizing tasks. Psychometrically, DSM-5-TR operationalizes modest impairment as approximately $-1$ to $-2$ standard deviations and substantial impairment as at or below $-2$ standard deviations relative to norms, but emphasizes that functional interference, not test scores alone, separates mild from major. For the vascular subtype, the cognitive profile often shows prominent deficits in complex attention, processing speed, and executive function, with real-world manifestations in IADL. Establishing the vascular etiology also requires clinical evidence of cerebrovascular disease (for example, neurological signs or neuroimaging findings) and a plausible relationship between that disease and the cognitive deficits (for example, temporal relation to a stroke or a pattern consistent with small vessel disease). DSM-5-TR allows the “concern” criterion to be met by report from the individual, a knowledgeable informant, or the clinician; it does not mandate an informant but encourages multimethod corroboration.\n\nWith these principles, consider why informant-based functional measures are useful. Cognitive tests assess capacity under standardized conditions and are subject to measurement error, practice effects, demographic influences (for example, education and language), and limited ecological validity. Informant-based functional scales capture real-world performance and changes from premorbid functioning, especially in IADL, and help determine whether independence is compromised (major) or preserved with added effort (mild). Informant collateral can also fulfill the DSM-5-TR requirement for evidence of decline by concern from a knowledgeable observer when self-report is limited by anosognosia or minimization. However, informant measures do not replace the need for neurological examination or neuroimaging to establish vascular etiology, nor do they “re-norm” objective cognitive scores; psychometric norms remain necessary.\n\nApply these principles to each option:\n\nA. This aligns directly with DSM-5-TR’s severity anchor. The informant’s report of missed bill payments, medication errors requiring assistance, and planning problems speaks to IADL compromise that is typical when executive and processing speed deficits (common in subcortical ischemic vascular disease) affect daily function. An informant-based functional scale quantifies this interference, helping differentiate mild versus major neurocognitive disorder. This is a defensible argument. Verdict — Correct.\n\nB. DSM-5-TR permits evidence of decline by concern from the individual, a knowledgeable informant, or the clinician; it does not require an informant in every case. While informant data are valuable, they are not mandatory. Verdict — Incorrect.\n\nC. Establishing vascular etiology requires clinical and/or neuroimaging evidence of cerebrovascular disease and a plausible relationship to the cognitive syndrome. An informant’s endorsement of stepwise decline after a stroke is supportive but cannot obviate the need for examination or imaging in determining etiology. Verdict — Incorrect.\n\nD. Informant scales do not “re-norm” cognitive test performance; they assess functional impact and change. Education and cultural effects on tests are addressed by appropriate normative corrections and test selection, not by substituting informant ratings for norms. Verdict — Incorrect.\n\nE. DSM-5-TR requires evidence of decline based on concern from the individual, a knowledgeable informant, or the clinician. In cases with limited self-awareness or minimization, an informant-based scale provides collateral concern, complementing objective testing to meet the diagnostic threshold. Verdict — Correct.\n\nTherefore, the defensible arguments are those in options A and E.", "answer": "$$\\boxed{AE}$$", "id": "4771233"}, {"introduction": "Modern clinical practice often involves integrating multiple sources of data to create a comprehensive picture of a patient's prognosis. This advanced exercise simulates the development of a prognostic model by combining various neuroimaging markers of small vessel disease into a single lesion load index. You will practice standardizing data, weighting it based on established risk factors, and using the resulting index to predict a patient's executive function score, reflecting a sophisticated, data-driven approach to patient care [@problem_id:4771256].", "problem": "A clinician is building a quantitative prognostic model for vascular neurocognitive disorder that integrates Magnetic Resonance Imaging (MRI) lesion metrics to predict an Executive Function Composite (EFC) score. Executive dysfunction in small vessel disease is strongly associated with lacunar infarcts and White Matter Hyperintensities (WMH). From epidemiological studies, changes in lesion metrics shift the odds of executive impairment in approximately multiplicative fashion on the odds scale, which is additive on the log-odds scale. To construct a composite Lesion Load Index (LLI), the clinician standardizes each lesion metric to a $z$-score using cohort statistics and assigns a weight equal to the natural logarithm of the odds ratio (OR) corresponding to a one-standard-deviation increase in that metric.\n\nBase definitions and facts to use:\n- A $z$-score for a metric $x$ is $z = (x - \\mu)/\\sigma$, where $\\mu$ is the cohort mean and $\\sigma$ is the cohort standard deviation.\n- The natural logarithm of an odds ratio rescales multiplicative effects on odds to additive effects on log-odds.\n- If an odds ratio $\\mathrm{OR}_{\\Delta}$ pertains to an increment $\\Delta$ in a metric, then the odds ratio for a one-standard-deviation increment is $\\mathrm{OR}_{1\\sigma} = \\mathrm{OR}_{\\Delta}^{\\sigma/\\Delta}$, hence the corresponding log-odds weight is $w = \\ln(\\mathrm{OR}_{1\\sigma}) = (\\sigma/\\Delta)\\,\\ln(\\mathrm{OR}_{\\Delta})$.\n- The composite Lesion Load Index is $LLI = \\sum_{i} w_{i}\\,z_{i}$ across independent lesion metrics $i$.\n- A calibrated linear link between $LLI$ and expected EFC is $EFC_{\\mathrm{pred}} = \\mu_{\\mathrm{EFC}} + \\gamma \\cdot LLI$, with $\\gamma$ negative because greater lesion load worsens executive function.\n\nData for a single patient:\n- Number of lacunes $N = 11$.\n- Total lacunar volume $V_{L} = 3.3$ $\\mathrm{mL}$.\n- WMH volume $V_{W} = 42$ $\\mathrm{mL}$.\n- Intracranial Volume (ICV) $ICV_{\\mathrm{patient}} = 1500$ $\\mathrm{mL}$.\n\nCohort summary for standardization:\n- Mean lacune count $\\mu_{N} = 4$ and standard deviation $\\sigma_{N} = 6$.\n- Mean normalized lacunar volume $\\mu_{VL,\\mathrm{norm}} = 0.0015$ and standard deviation $\\sigma_{VL,\\mathrm{norm}} = 0.0010$, where $V_{L,\\mathrm{norm}} = V_{L}/ICV$.\n- Mean normalized WMH volume $\\mu_{VW,\\mathrm{norm}} = 0.020$ and standard deviation $\\sigma_{VW,\\mathrm{norm}} = 0.015$, where $V_{W,\\mathrm{norm}} = V_{W}/ICV$.\n\nOdds ratios for executive impairment associated with lesion increments (derived from prior studies):\n- For lacune count, per increment of $\\Delta_{N} = 5$ lacunes, $\\mathrm{OR}_{N,\\Delta} = 1.5$.\n- For lacunar volume, per increment of $\\Delta_{VL} = 5$ $\\mathrm{mL}$, $\\mathrm{OR}_{VL,\\Delta} = 1.25$.\n- For WMH volume, per increment of $\\Delta_{VW} = 20$ $\\mathrm{mL}$, $\\mathrm{OR}_{VW,\\Delta} = 1.9$.\n\nTo convert volumetric increments to normalized units comparable to the cohort standard deviations, use the cohort-average Intracranial Volume (ICV) $ICV_{\\mathrm{avg}} = 1450$ $\\mathrm{mL}$. Thus $\\Delta_{VL,\\mathrm{norm}} = \\Delta_{VL}/ICV_{\\mathrm{avg}}$ and $\\Delta_{VW,\\mathrm{norm}} = \\Delta_{VW}/ICV_{\\mathrm{avg}}$.\n\nCalibration for EFC prediction:\n- $EFC_{\\mathrm{pred}} = \\mu_{\\mathrm{EFC}} + \\gamma \\cdot LLI$ with $\\mu_{\\mathrm{EFC}} = 55$ points and slope $\\gamma = -8$ points per unit of $LLI$.\n\nTask:\n1. Compute the patient’s normalized lacunar and WMH volumes, $V_{L,\\mathrm{norm}}$ and $V_{W,\\mathrm{norm}}$.\n2. Compute the $z$-scores $z_{N}$, $z_{VL}$, and $z_{VW}$ using the provided cohort means and standard deviations.\n3. Convert each odds ratio per increment to its corresponding log-odds weight for a one-standard-deviation increase: $w_{N}$, $w_{VL}$, and $w_{VW}$, with volumetric increments expressed in normalized units using $ICV_{\\mathrm{avg}}$.\n4. Compute $LLI = w_{N}z_{N} + w_{VL}z_{VL} + w_{VW}z_{VW}$.\n5. Compute $EFC_{\\mathrm{pred}}$ from $LLI$ using the calibration above.\n\nRound your final $EFC_{\\mathrm{pred}}$ to four significant figures and express it in points.", "solution": "The problem statement has been critically validated and is deemed sound. It is scientifically grounded, well-posed, objective, and internally consistent. All necessary data and definitions for constructing the prognostic model and calculating the patient's predicted score are provided. The model, while a simplification of complex clinical reality, uses standard statistical and biomedical principles (z-scores, odds ratios, linear combination of risk factors). The task is a direct application of the provided quantitative framework.\n\nThe calculation proceeds by following the five steps outlined in the problem statement.\n\nStep 1: Compute the patient’s normalized lacunar and WMH volumes.\nThe normalized volumes are calculated by dividing the absolute volumes by the patient's specific Intracranial Volume ($ICV_{\\mathrm{patient}}$).\nGiven: patient's lacunar volume $V_{L} = 3.3$ $\\mathrm{mL}$, patient's WMH volume $V_{W} = 42$ $\\mathrm{mL}$, and patient's Intracranial Volume $ICV_{\\mathrm{patient}} = 1500$ $\\mathrm{mL}$.\n\nThe patient's normalized lacunar volume, $V_{L,\\mathrm{norm}}$, is:\n$$V_{L,\\mathrm{norm}} = \\frac{V_{L}}{ICV_{\\mathrm{patient}}} = \\frac{3.3}{1500} = 0.0022$$\n\nThe patient's normalized White Matter Hyperintensity volume, $V_{W,\\mathrm{norm}}$, is:\n$$V_{W,\\mathrm{norm}} = \\frac{V_{W}}{ICV_{\\mathrm{patient}}} = \\frac{42}{1500} = 0.028$$\n\nStep 2: Compute the $z$-scores for each lesion metric.\nThe $z$-score is calculated using the formula $z = (x - \\mu)/\\sigma$, where $x$ is the patient's metric value, and $\\mu$ and $\\sigma$ are the cohort mean and standard deviation, respectively.\n\nFor the number of lacunes, $N$:\nPatient value $N=11$, cohort mean $\\mu_{N} = 4$, and standard deviation $\\sigma_{N} = 6$.\n$$z_{N} = \\frac{N - \\mu_{N}}{\\sigma_{N}} = \\frac{11 - 4}{6} = \\frac{7}{6}$$\n\nFor the normalized lacunar volume, $V_{L,\\mathrm{norm}}$:\nPatient value $V_{L,\\mathrm{norm}} = 0.0022$, cohort mean $\\mu_{VL,\\mathrm{norm}} = 0.0015$, and standard deviation $\\sigma_{VL,\\mathrm{norm}} = 0.0010$.\n$$z_{VL} = \\frac{V_{L,\\mathrm{norm}} - \\mu_{VL,\\mathrm{norm}}}{\\sigma_{VL,\\mathrm{norm}}} = \\frac{0.0022 - 0.0015}{0.0010} = \\frac{0.0007}{0.0010} = 0.7$$\n\nFor the normalized WMH volume, $V_{W,\\mathrm{norm}}$:\nPatient value $V_{W,\\mathrm{norm}} = 0.028$, cohort mean $\\mu_{VW,\\mathrm{norm}} = 0.020$, and standard deviation $\\sigma_{VW,\\mathrm{norm}} = 0.015$.\n$$z_{VW} = \\frac{V_{W,\\mathrm{norm}} - \\mu_{VW,\\mathrm{norm}}}{\\sigma_{VW,\\mathrm{norm}}} = \\frac{0.028 - 0.020}{0.015} = \\frac{0.008}{0.015} = \\frac{8}{15}$$\n\nStep 3: Compute the log-odds weights for a one-standard-deviation increase.\nThe weight $w$ is given by $w = (\\sigma/\\Delta)\\,\\ln(\\mathrm{OR}_{\\Delta})$. For volumetric metrics, the increment $\\Delta$ based on absolute volume must be normalized using the cohort-average ICV, $ICV_{\\mathrm{avg}} = 1450$ $\\mathrm{mL}$.\n\nFor the number of lacunes, $N$:\n$\\sigma_{N} = 6$, $\\Delta_{N} = 5$ lacunes, $\\mathrm{OR}_{N,\\Delta} = 1.5$.\n$$w_{N} = \\frac{\\sigma_{N}}{\\Delta_{N}}\\ln(\\mathrm{OR}_{N,\\Delta}) = \\frac{6}{5}\\ln(1.5) = 1.2\\ln(1.5)$$\n\nFor the normalized lacunar volume, $V_{L,\\mathrm{norm}}$:\n$\\sigma_{VL,\\mathrm{norm}} = 0.0010$. The increment is $\\Delta_{VL} = 5$ $\\mathrm{mL}$. The normalized increment is $\\Delta_{VL,\\mathrm{norm}} = \\Delta_{VL} / ICV_{\\mathrm{avg}} = 5 / 1450 = 1/290$. The odds ratio is $\\mathrm{OR}_{VL,\\Delta} = 1.25$.\n$$w_{VL} = \\frac{\\sigma_{VL,\\mathrm{norm}}}{\\Delta_{VL,\\mathrm{norm}}}\\ln(\\mathrm{OR}_{VL,\\Delta}) = \\frac{0.0010}{5/1450}\\ln(1.25) = \\frac{0.0010 \\times 1450}{5}\\ln(1.25) = 0.29\\ln(1.25)$$\n\nFor the normalized WMH volume, $V_{W,\\mathrm{norm}}$:\n$\\sigma_{VW,\\mathrm{norm}} = 0.015$. The increment is $\\Delta_{VW} = 20$ $\\mathrm{mL}$. The normalized increment is $\\Delta_{VW,\\mathrm{norm}} = \\Delta_{VW} / ICV_{\\mathrm{avg}} = 20 / 1450 = 2/145$. The odds ratio is $\\mathrm{OR}_{VW,\\Delta} = 1.9$.\n$$w_{VW} = \\frac{\\sigma_{VW,\\mathrm{norm}}}{\\Delta_{VW,\\mathrm{norm}}}\\ln(\\mathrm{OR}_{VW,\\Delta}) = \\frac{0.015}{20/1450}\\ln(1.9) = \\frac{0.015 \\times 1450}{20}\\ln(1.9) = 1.0875\\ln(1.9)$$\n\nStep 4: Compute the Lesion Load Index ($LLI$).\nThe $LLI$ is the sum of the products of the weights and their corresponding $z$-scores: $LLI = w_{N}z_{N} + w_{VL}z_{VL} + w_{VW}z_{VW}$.\n$$LLI = \\left(1.2\\ln(1.5)\\right)\\left(\\frac{7}{6}\\right) + \\left(0.29\\ln(1.25)\\right)\\left(0.7\\right) + \\left(1.0875\\ln(1.9)\\right)\\left(\\frac{8}{15}\\right)$$\nSimplifying the coefficients:\n$$LLI = \\left(1.2 \\times \\frac{7}{6}\\right)\\ln(1.5) + (0.29 \\times 0.7)\\ln(1.25) + \\left(1.0875 \\times \\frac{8}{15}\\right)\\ln(1.9)$$\n$$LLI = 1.4\\ln(1.5) + 0.203\\ln(1.25) + 0.58\\ln(1.9)$$\nNow, we substitute the values of the natural logarithms:\n$\\ln(1.5) \\approx 0.4054651$, $\\ln(1.25) \\approx 0.2231436$, $\\ln(1.9) \\approx 0.6418539$.\n$$LLI \\approx 1.4(0.4054651) + 0.203(0.2231436) + 0.58(0.6418539)$$\n$$LLI \\approx 0.5676511 + 0.0453001 + 0.3722753$$\n$$LLI \\approx 0.9852265$$\n\nStep 5: Compute the predicted Executive Function Composite score ($EFC_{\\mathrm{pred}}$).\nThe prediction is given by the linear model $EFC_{\\mathrm{pred}} = \\mu_{\\mathrm{EFC}} + \\gamma \\cdot LLI$.\nGiven $\\mu_{\\mathrm{EFC}} = 55$ and $\\gamma = -8$.\n$$EFC_{\\mathrm{pred}} = 55 - 8 \\cdot LLI$$\n$$EFC_{\\mathrm{pred}} \\approx 55 - 8 \\times 0.9852265$$\n$$EFC_{\\mathrm{pred}} \\approx 55 - 7.881812$$\n$$EFC_{\\mathrm{pred}} \\approx 47.118188$$\nThe problem requires rounding the final answer to four significant figures. The first four significant figures are $4$, $7$, $1$, $1$. The fifth digit is $8$, so we round up the fourth digit.\n$$EFC_{\\mathrm{pred}} \\approx 47.12$$", "answer": "$$\n\\boxed{47.12}\n$$", "id": "4771256"}]}